Translational solutions.

MesenFlow Technologies Sàrl

Incorporated

26.03.2018

Headquarters

Plan-les-Ouates

Support

MesenFlow Technologies will provide the world's first bioimaging platform service dedicated to accelerating drug development and cosmetic testing by using proprietary hi-throughput models of human disease and inflammation. Their mission is to evaluate compound safety, efficacy & mechanism in early discovery, leading to reduced attrition in the clinical phase.